|
greenovation is a privately
held biotechnology company based in Freiburg, Germany. The company was
founded in 1999 as a university spin-off. Venture capital investors
are Mediport Venture Fond II, Berlin, Seed Venture, Karlsruhe, and
L-EA, Karlsruhe. In cooperation with pharmaceutical companies,
greenovation develops the moss production strains for
biopharmaceuticals. For its glycosylation research, greenovation is
also collaborating with the University of Freiburg and the University
of Natural Resources and Applied Life Sciences, Vienna, Austria.
|
